"Ilus, Tuire" - Selaus tekijän mukaan TUNICRIS-julkaisut
Viitteet 1-5 / 5
-
Combining biological therapies in patients with inflammatory bowel disease : a Finnish multi-centre study
(2022)
articleBackground and aims: Therapy with two concomitant biologicals targeting different inflammatory pathways has emerged as a new therapy option for treatment refractory inflammatory bowel disease (IBD). Data on the efficacy ... -
Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroids
(2021)
articleBackground and aims: Every fifth patient with ulcerative colitis (UC) experiences severe acute flare at some point in the course of the disease. Corticosteroids (Cs) remain the treatment of choice in acute flare. Data on ... -
Long-term outcomes of patients with acute severe ulcerative colitis treated with cyclosporine rescue therapy
(2023)
articleBACKGROUND AND AIMS: The early outcomes of ulcerative colitis (UC) after rescue therapy with cyclosporine A (CyA) are well known. Published data on the safety of this treatment in perioperative use and data on the long-term ... -
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in Finland
(04 / 2021)
articleBackground: Real-world evidence to support optimal ustekinumab dosing for refractory Crohn’s disease (CD) patients remains limited. Data from a retrospective nationwide chart review study was utilized to explore ustekinumab ... -
Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment
(30.06.2024)
articlePurpose: To analyze treatment persistence and treatment outcomes of vedolizumab as first-line biological treatment in Crohn's disease (CD) and ulcerative colitis (UC) patients in a Finnish real-world setting. Methods: ...
